Authors: Nasu, Y Bangma, CH Hull, GW Yang, G Wang, J Shimura, S McCurdy, MA Ebara, S Lee, HM Timme, TL Thompson, TC

Citation: Y. Nasu et al., Combination gene therapy with adenoviral vector-mediated HSV-tk plus GCV and IL-12 in an orthotopic mouse model for prostate cancer, PROSTATE C, 4(1), 2001, pp. 44-55

Authors: Hull, GW McCurdy, MA Nasu, Y Bangma, CH Yuang, G Shimura, S Lee, HM Wang, JX Albani, J Ebara, S Sato, T Timme, TL Thompson, TC

Citation: Gw. Hull et al., Prostate cancer gene therapy: Comparison of adenovirus-mediated expressionof interleukin 12 with interleukin 12 plus B7-1 for in situ gene therapy and gene-modified, cell-based vaccines, CLIN CANC R, 6(10), 2000, pp. 4101-4109

Authors: Nasu, Y Bangma, CH Hull, GW Lee, HM Wang, J McCurdy, MA Shimura, S Yang, G Timme, TL Thompson, TC

Citation: Y. Nasu et al., Adenovirus-mediated interleukin-12 gene therapy for prostate cancer: suppression of orthotopic tumor growth and pre-established lung metastases in anorthotopic model, GENE THER, 6(3), 1999, pp. 338-349

Authors: Adler, HL McCurdy, MA Kattan, MW Timme, TL Scardino, PT Thompson, TC

Citation: Hl. Adler et al., Elevated levels of circulating interleukin-6 and transforming growth factor-beta 1 in patients with metastatic prostatic carcinoma, J UROL, 161(1), 1999, pp. 182-187